Literature DB >> 6308069

A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa.

H Gross, M H Ebert, V B Faden, S C Goldberg, W H Kaye, E D Caine, R Hawks, N Zinberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6308069

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  24 in total

Review 1.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 2.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

3.  Cannabis: dangers and possible uses.

Authors:  C H Ashton
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

4.  Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.

Authors:  Cindy Casteels; Nathalie Gérard; Kris van Kuyck; Lies Pottel; Bart Nuttin; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-05       Impact factor: 9.236

5.  The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.

Authors:  Aaron N A Verty; Megan J Evetts; Geraldine J Crouch; Iain S McGregor; Aneta Stefanidis; Brian J Oldfield
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

6.  The novel cannabinoid CB1 receptor agonist AM11101 increases food intake in female rats.

Authors:  Sean B Ogden; Michael S Malamas; Alexandros Makriyannis; Lisa A Eckel
Journal:  Br J Pharmacol       Date:  2019-09-06       Impact factor: 8.739

Review 7.  Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 8.  Treatment studies with cannabinoids in anorexia nervosa: a systematic review.

Authors:  Emilie Vangsgaard Rosager; Christian Møller; Magnus Sjögren
Journal:  Eat Weight Disord       Date:  2020-04-02       Impact factor: 4.652

Review 9.  Cannabinoids in eating disorders and obesity.

Authors:  Francisco Arias Horcajadas
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

10.  Facilitory effect of delta 9-tetrahydrocannabinol on hypothalamically induced feeding.

Authors:  W Trojniar; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.